[Vincristine-induced encephalopathies during treatment of childhood leukemias].
D000419:Albuminuria; D002490:Central Nervous System / Q000187:drug effects; D002648:Child; D002712:Chlorides / Q000097:blood; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D011188:Potassium / Q000097:blood; D012640:Seizures / Q000139:chemically induced*; D012964:Sodium / Q000097:blood; D013046:Specific Gravity; D014474:Unconsciousness / Q000139:chemically induced*; D014508:Urea / Q000652:urine; D014556:Urine; D014750:Vincristine / Q000009:adverse effects* / Q000627:therapeutic use
D002712:Chlorides; D014750:Vincristine; D014508:Urea; D012964:Sodium; D011188:Potassium
Vincristin-induzierte Encephalopathien unter der Behandlung kindlicher Leukosen.